Kian-Huat Lim, MD, PhD, a researcher and medical oncologist at Siteman Cancer Center, has received a 2016 Career Development Award from the Pancreatic Cancer Action Network and the American Association for Cancer Research. Each year, the organizations jointly recognize early-career pancreatic cancer researchers.
Lim will receive a two-year, $200,000 grant as part of the award. Lim’s research is based on his lab’s findings that pancreatic cancer cells resist chemotherapy and become aggressive by frequently activating their own immune defense mechanism. By deactivating this mechanism, Lim’s team is able to render pancreatic cancer cells more sensitive to chemotherapy.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.